CorpusHuman Anatomy
EndocrineHormone

Secretin

A 27-amino-acid peptide from duodenal S cells, released when acid enters the duodenum, that stimulates bicarbonate-rich pancreatic and biliary secretion and inhibits gastric acid — "nature's antacid" and the first hormone ever discovered.

Show on body map

Overview

ClassPeptide (27 aa)
ReceptorSecretin receptor — Gs
StimulusDuodenal pH <≈4.5

Secretin was discovered by Bayliss and Starling in 1902, giving rise to the word "hormone". S cells in the duodenal (and upper jejunal) mucosa release it when chyme lowers duodenal pH below ≈4.5 (fatty acids also contribute). Acting through the secretin receptor (Gs/cAMP), it stimulates pancreatic duct cells to secrete a large volume of HCO₃⁻-rich fluid via the CFTR chloride channel and apical Cl⁻/HCO₃⁻ exchange, and stimulates bicarbonate secretion by cholangiocytes and Brunner glands. The bicarbonate neutralises gastric acid, protecting the duodenal mucosa and providing the near-neutral pH at which pancreatic enzymes work.

It also inhibits gastrin release and gastric acid secretion, slows gastric emptying and potentiates the action of CCK on the pancreas.

Location

Source: S cells of the duodenal and proximal jejunal mucosa. Targets: pancreatic duct cells, bile duct epithelium, stomach.

Function

  • Stimulates pancreatic and biliary bicarbonate secretion.
  • Inhibits gastric acid secretion and gastrin release.
  • Slows gastric emptying.
Physiology

Class: peptide (27 aa; glucagon family). Receptor: secretin receptor — Gs/cAMP.

Regulation

Released by duodenal acid (pH <≈4.5) and fatty acids; secretion falls once acid is neutralised.

Clinical significance

Secretin tests

In Zollinger–Ellison syndrome, IV secretin paradoxically increases gastrin (gastrinoma cells express secretin receptors). Secretin-enhanced MRCP improves visualisation of pancreatic ducts; the secretin stimulation test assesses exocrine pancreatic function.

Cystic fibrosis

Defective CFTR prevents secretin-driven bicarbonate and fluid secretion, so viscous secretions block pancreatic ducts, causing exocrine pancreatic insufficiency.

Compiled from standard anatomy and physiology references — see the Endocrine System sources. For education only; not medical advice.